Sodium Valproate .... NTI? [Regulatives / Guidelines]

posted by hari emmadi – India, 2016-09-21 12:19 (2766 d 13:38 ago) – Posting: # 16655
Views: 2,132

Dear All,

Greetings....

We are planning to conduct bioequivalence study of sodium valproate crushable tablets 100 mg for TGA submission. Sodium valproate is CNS category of drug. In view of this, we would like to know whether this drug falls under category of narrow therapeutic index (NTI) or not?

Complete thread:

UA Flag
Activity
 Admin contact
22,986 posts in 4,823 threads, 1,671 registered users;
94 visitors (0 registered, 94 guests [including 8 identified bots]).
Forum time: 01:57 CEST (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5